Case Study: Ventilation Optimization in Sterile Injectable Drug Manufacturing

A leading U.S. sterile injectable drug manufacturer sought to expand its laboratory facilities as part of a large-scale design-build project. With safety and sustainability in mind, they needed a ventilation control system that could precisely regulate airflow while optimizing energy use.

The company, experiencing rapid growth, needed to scale its facilities profitably. Leadership prioritized sustainability as a core value, requiring a solution that would both support compliance and reduce long-term operating expenses.

As part of its new finishing center, the company selected AntrumX® to integrate with its VAV laboratory control system. Deployed in critical spaces such as the micro-lab and sample receipt lab, AntrumX ensured real-time detection of contaminants and automated ventilation adjustments. Paired with AntrumEYE®, the system provided:

• Monitoring of approximately 10,000 square feet of laboratory space
• Real-time data on air quality and ventilation performance
• Energy savings metrics, including kWh reduced and CO₂ emissions avoided
• A science-based, information-driven approach to energy efficiency

The system delivered a 40% reduction in ventilation demand, significantly lowering operating expenses without compromising safety.

By cutting ventilation demand by 40%, the company directly reduced operating expenses in a way that supported its rapid growth. AntrumX became more than an energy solution—it became a growth strategy, allowing the company to expand profitably while staying true to its core values of safety and sustainability.